A nurse is caring for a client.

• Medication Administration Record:

  • Budesonide 6 mg PO daily.

• Laboratory Results:

  • Hematocrit (Hct): 47% (Normal range: 37% to 52%)
  • Hemoglobin (Hgb): 16 g/dL (Normal range: 12 to 18 g/dL)
  • Potassium: 3.6 mEq/L (Normal range: 3.5 to 5.0 mEq/L)

• History and Physical:

  • BMI: 16 (Reference Range:18.5 - 24.9)
  • History of type 2 diabetes mellitus.
  • Nonsmoker.
  • New diagnosis of Crohn's disease.

Click to highlight the findings that increase the client's susceptibility to infection.

To deselect a finding, click on the finding again.

The correct answer is Choice A, Choice B

Choice A rationale: Clostridium difficile is a spore-forming, gram-positive anaerobic bacillus that causes antibiotic-associated colitis. Transmission occurs via the fecal-oral route, primarily through contact with contaminated surfaces or hands. Protective gowns are essential during care to prevent spore transfer to clothing and subsequent environmental contamination. Spores resist alcohol-based sanitizers and persist on surfaces for months. Contact precautions, including gown use, reduce nosocomial spread. Normal white blood cell count is 4,000–11,000/mm³; elevated levels may indicate infection severity.

Choice B rationale: Isolation in a private room is critical for clients with confirmed Clostridium difficile infection due to the organism’s ability to form resilient spores that contaminate surfaces and equipment. Private rooms limit environmental exposure and reduce cross-contamination risk. C. difficile spores are resistant to routine cleaning agents and require bleach-based disinfectants. Diarrheal stool volume increases transmission risk. Normal stool frequency is 1–3 formed stools/day; 4–5 liquid stools/day indicates active infectious diarrhea requiring isolation.

Choice C rationale: N-95 respirators are designed for airborne pathogens such as Mycobacterium tuberculosis, measles virus, or varicella-zoster virus. Clostridium difficile is not airborne; it transmits via contact with contaminated surfaces or hands. Spores are shed in feces and do not aerosolize under normal conditions. Therefore, N-95 respirators offer no added protection against CDI. Airborne precautions are unnecessary unless aerosol-generating procedures are performed on patients with concurrent airborne infections. Respiratory rate normal range is 12–20 breaths/min.

Choice D rationale: Negative pressure rooms are used to contain airborne pathogens by maintaining lower air pressure inside the room, preventing contaminated air from escaping. Clostridium difficile does not spread via airborne particles but through contact with contaminated surfaces and feces. Thus, negative pressure rooms are not scientifically justified for CDI. Instead, contact isolation and environmental decontamination are prioritized. Room air exchanges are irrelevant to CDI control. Normal room air pressure is neutral unless airborne precautions are indicated.

Choice E rationale: Masking the client is a droplet precaution used for pathogens like influenza virus, Neisseria meningitidis, or SARS-CoV-2. Clostridium difficile does not transmit via respiratory droplets, so placing a mask on the client during transport does not reduce transmission risk. Instead, hand hygiene and contact precautions are essential. CDI spores are not expelled via coughing or sneezing. Droplet precautions are reserved for pathogens with particle size >5 µm. Normal oxygen saturation is ≥95% on room air.

Choice A rationale:

The statement "Identifies viruses across the world" is not an accurate description of the Healthy People 2030 framework. This framework focuses on health objectives and goals for Americans, not the identification of viruses. It is designed to improve the health and well-being of people in the United States, not to identify viruses globally.

Choice C rationale:

The statement "Utilizes health data from the past 20 years" is not a primary purpose of the Healthy People 2030 framework. While it may incorporate historical health data to inform its objectives, the framework's main goal is to set health objectives for the future, not exclusively based on past data. It aims to address current and future health needs and challenges.

Choice D rationale:

The statement "Monitors nonmodifiable risk factors" does not accurately describe the main focus of the Healthy People 2030 framework. While the framework may consider various health risk factors, it primarily concentrates on setting health objectives and goals to improve the health of Americans. The monitoring of nonmodifiable risk factors is not its central purpose.